Àâòîðèçàöèÿ
Ïîèñê ïî óêàçàòåëÿì
Gomperts B.D., Tatham P.E.R., Kramer I.M. — Signal Transduction
Îáñóäèòå êíèãó íà íàó÷íîì ôîðóìå
Íàøëè îïå÷àòêó? Âûäåëèòå åå ìûøêîé è íàæìèòå Ctrl+Enter
Íàçâàíèå: Signal Transduction
Àâòîðû: Gomperts B.D., Tatham P.E.R., Kramer I.M.
Àííîòàöèÿ: Signal Transduction is a text reference on cellular signalling processes. Starting with the basics, it explains how cells respond to external cues (hormones, cytokines, neurotransmitters, adhesion molecules, extracellular matrix, etc), and shows how these inputs are integrated and co-ordinated. The first half of the book provides the conceptual framework, explaining the formation and action of second messengers, particulary cyclic nucleotides and calcium, and the mediation of signal pathways by GTP-binding proteins. The remaining chapters deal with the formation of complex signalling cascades employed by cytokines and adhesion molecules, starting at the membrane and ending in the nucleus, there to regulate gene transcription. In this context, growth is an important potential outcome and this has relevance to the cellular transformations that underlie cancer. The book ends with a description at the molecular level of how signalling proteins interact with their environment and with each other through their structural domains. Each main topic is introduced with a historical essay, detailing the sources key observations and experiments that set the scence for recent and current work.
ßçûê:
Ðóáðèêà: Òåõíîëîãèÿ /
Ñòàòóñ ïðåäìåòíîãî óêàçàòåëÿ: Ãîòîâ óêàçàòåëü ñ íîìåðàìè ñòðàíèö
ed2k: ed2k stats
Ãîä èçäàíèÿ: 2002
Êîëè÷åñòâî ñòðàíèö: 424
Äîáàâëåíà â êàòàëîã: 21.12.2005
Îïåðàöèè: Ïîëîæèòü íà ïîëêó |
Ñêîïèðîâàòü ññûëêó äëÿ ôîðóìà | Ñêîïèðîâàòü ID
Ïðåäìåòíûé óêàçàòåëü
145—168 171—185
ionophores 150
, adenylyl cyclase regulation 109 112 115
, bound 148—149
, complex formation 147—148
, cytosolic levels 149—166
, cytosolic levels, detection of changes 150—153 152 261
, cytosolic levels, elevation effects 172—173
, cytosolic levels, elevation mechanisms 153—162
, cytosolic levels, patterns of change in single cells 162—166 163 164 165
, electrically excitable cells 165—166
, free 148—149 148
, homeostasis 149
, intracellular localization 166—168
, intracellular localization, eukaryotic cell compartmentalization 146—147
, muscle contraction 165 166 182—185
, neurotransmitter secretion triggering 181—182
, PKC activation 199 200
, second messenger function 25 145—147 275
, trapped 148
, visual transduction 127 130
, visual transduction, negative regulation 135-137
-ATPase 149
-binding proteins 136 149 171—172 772
-binding proteins, polypeptide modules 401—403
-calmodulin-dependent protein kinase II see "CaM-kinase II"
-calmodulin-sensitive adenylyl cyclase/phosphodiesterase 176—177
-dependent adhesion molecules 320
-dependent enzymes 172 178—180
-induced release see "CICR"
-sensing receptors 56—57
-sensitive photoproteins 150—151
receptor 215 316—317
-receptor 291 292
147—148
, free 148 149
see “Ras-GAP”
241 249 370
241 249
241
241
211 241 242 246 330 370
241 242 246
262—263 263
215
241 246
215 216
, phosphorylation 215—217
271
271
75 121 122 123 124
, G-protein $\alpha%-subunit activation 80
, G-protein-coupled activation 123—124
121—122 123 124
121 122 123 124
, activation 124—125 261
, T cell activation 285 287
294
231
19 20 231 232
family 359—364 360
receptors 359—362
, -mediated activation 362 364 364
, accessory 362 363
, overexpression 368—369
, Smads regulation 366 367
, type I ( ) 359 360—361 360 361 369
, type II (T\beta R-II) 359 360 361 369
, type III 362 363
359 362 363
, receptor activation 362 364 364
(tumour necrosis factoru) 23 348—349
receptor signalling complex 349 350
, endothelial cell adhesion molecule regulation 349—351
(tumour necrosis factor ) 349
359 360—361 360 361 369
359 360 361 361 369
-actinin 180
-adrenergic receptors 34 34 107 194
-adrenergic receptors, subtypes 35 35
-bungarotoxin 43—44
-type mating factor 3 96
-adrenergic receptors 34 34 52 107 185 196
-adrenergic receptors, adenylyl cyclase activation 63 75 191
-adrenergic receptors, antagonists ( -blockers) 35 36 55 60
-adrenergic receptors, dimerization 61 62
-adrenergic receptors, inverse agonists 60
-adrenergic receptors, overexpression 60
-adrenergic receptors, subtypes 35 35
-adrenergic receptors, transduction system construction in Sf9 cells 98—99 99
-Catenin 249 333 334
-catenin, mutations in cancer 334 334
-Endorphin 4
ARK ( -adrenergic receptor kinase) 84 85 197 276—277 278
-Aminobutyric acid see “GABA”
11-cis-retinal 130 132 733
11-cis-retinal, light-induced isomerization 137 738
11-cis-retinal, rhodopsin interaction 54
3-phosphoinositide dependent protein kinase-1 see “PDK1”
5-hydroxytryptamine see “Serotonin”
7TM receptors 38 40 51—58 see
7TM receptors, binding to low molecular mass ligands 55
7TM receptors, calcium sensors 56—57
7TM receptors, categories 52 54—55 54
7TM receptors, ERK activation 276—279
7TM receptors, G-protein linkage 72 73 99
7TM receptors, intracellular domains 65—66
7TM receptors, ligand binding sites 57
7TM receptors, metabotropic 42 56—57
7TM receptors, signal transmission 65—66
a-type mating factor 3 96
A2387 150
Abelson murine leukaemia virus see "v-Abl"
Acetylcholine 11 14 38—39
Acetylcholine (cholinergic) receptors 38—42
Acetylcholine, cholinergic receptor interactions 40 42
Acetylcholine, cholinergic receptor interactions, muscarinic receptors 55
Acetylcholine, cholinergic receptor interactions, nicotinic receptors 44 49
Acetylcholine, neuromuscular junction actions 24
Acetylcholinesterase 38
Acetylcholinesterase inhibitors 39 39
ACTH (adrenocorticotrophic hormone) 4 20
ACTH, adenylyl cyclase activation 62 64—65 65
ACTH, receptor binding 55
Actin 182 325 329 332
Activator protein complex-1 see "AP-1"
Adenine 62 63
Adenosine receptor 63
Adenosine receptor, homodimers 62
Adenosis poliposis coli see "APC"
Adenylyl cyclase 55 62—63 63 107—119
Adenylyl cyclase, -calmodulin-sensitive 176—177
Adenylyl cyclase, activation by receptors 62—63 63 64
Adenylyl cyclase, activation by receptors, experimental approaches 63-65 65
Adenylyl cyclase, ATP conversion to cAMP 72 109 109 110
Adenylyl cyclase, constitutive activity 59
Adenylyl cyclase, G-protein -subunit interactions 80 96 109 110 112 113 113
Adenylyl cyclase, G-protein -subunit interactions 109 110 112 113—115 113
Adenylyl cyclase, GTP cofactor 72
Adenylyl cyclase, regulation 109—110 112—119 112 114
Adenylyl cyclase, structural organization 110—112 111
ADH (antidiuretic hormone) see "Vasopressin"
Adherens junctions 321—322 322 331—332
Adherens junctions, cell polarity maintenance 332 332
Adhesion molecules 212 249 315—325 316
Adhesion molecules, cell cycle regulation 328—330 330 331
Adhesion molecules, cell survival promotion 325—328 327
Adhesion molecules, leukocyte trafficking 345—355
Adhesion molecules, nomenclature 318
Adhesion molecules, T cell activation 285
Adhesion molecules, tumour suppression 331—334
ADP ribosylation 116—119 117
Adrenaline (epinephrine) 2 9 20 22 31 32 33 62 66
Adrenaline, actions 33—34
Adrenaline, adrenergic receptor interactions 29 36 38
Adrenaline, historical aspects 8 9—10
Adrenergic receptors 31 32 34—38 34
Adrenergic receptors, adrenaline interactions 29 36 38
Adrenergic receptors, agonists 35—36 35
Adrenergic receptors, antagonists 35 36 60
Adrenergic receptors, G-protein signalling 51 115
Adrenergic receptors, ligand structural features 36 37 38
Adrenergic receptors, membrane spanning sequences/topology 51 52 53
Adrenergic receptors, subtypes 35 35 36
Adrenocorticotrophic hormone see "ACTH"
Aequorin 150—151
AGC protein kinases 310 311
Aggrecan 324
Agonists 59 60 76 77
AIF (apoptosis inducing factor) 340
All-trans-retinal 132 133 137 139
Aluminium fluoride, adenylyl cyclase regulation 115—116
Amino acid receptors 42
AMPA receptors 158
Anaphase 238
Anaphase promoting complex/cyclosome see "APC/C"
Anergy 285
ANF (atrial natriuretic factor) 4 20
Angiogenesis 248—249
Angiogenic factors 248 249
Angiotensin 36
Annexins 171
Antagonists 59 60
Antidiuretic hormone (ADH) see "Vasopressin"
AP-1 (activator protein complex-1) 208 265 272 288
Apaf (apoptotic protease activating factor) 338 339
APC (adenosis poliposis coli) 249 333
APC, mutations in cancer 334 334
APC/C (anaphase promoting complex/cyclosome) 238 240 244 245
Apoptosis 22 179 227 240 242 248 249 325 326 335—340
Apoptosis inducing factor see "AlF"
Apoptosis, avoidance (rescue pathway) 325—328
Apoptosis, bcl-2 338—339 338
Apoptosis, caspases 335—338
Apoptosis, cell morphology 335 336
Apoptosis, cytochrome c 339—340 340
Apoptosis, Fas ligand 339 339
Apoptosis, JNK pathway 327—328 328
Apoptotic protease activating factor see "Apaf"
Arachidonate 23 23 204
Arf 86
Arrestin 84 139 276
Aspirin 23 299
Atenolol 37
ATM 243
ATP 19 71—72
ATP, cyclic AMP formation 109 109 110
Atrial natriuretic factor see "ANF"
Atropine 11 15 40
Avian erythroblastosis virus 229
Avian leukaemia viruses 225—226
B lymphocyte receptor 283
b558 215
B7 288
Bacteriorhodopsin 51 66
Bad (Bcl associated dimer) 326 339 340
Basophils 23 212 288
Bax 242 340
Bcl associated dimer see "Bad"
Bcl-2 249 337 338—339 338
Bcl-XI 249
Betaglycan 362
Bid 340
Binding affinity 25 26
Binding affinity, measurement 26—27 28
Binding reactions 25—28
Binding site heterogeneity 26
Boss (bride-of-sevenless) 266 267
Bradykinin 23
Brevican 324
Bride-of-sevenless see "Boss"
Btk (Bruton’s tyrosine kinase) 80 294
Bub2 244
Bubl 244 245
C-terminal Src kinase see "Csk"
C2 domain 171 179 181 402—403 403
C3bi 316
CAD (caspase activated DNAase) 226
Cadherins 249 320—322 327 322 331 332
Cadherins, classification 322
Cadherins, contact inhibition 334
cADPr (cyclic ADP-ribose) 159 160 760
Caenorhabditis elegans, Smad homologues 366 368
Caenorhabditis elegans, TGF receptor homologues 361 364—365
Caenorhabditis elegans, vulval cell development 268—269 269
CAK (CDK activating kinase) 235 237
Calcineurin (PP2B) 177 177 190 384 386 387
Calcineurin, T cell proliferation regulation 388—390 389
Calmodulin 154 173—174 174 175 275 388
Calmodulin, adenylyl cyclase regulation 112
Calmodulin, glycogenolysis regulation 175 176
Calpain 179
Calreticulin 149
CaM-kinase II ( -calmodulin-dependent protein kinase II) 156 175 275
CaM-kinases 174—175 184
Cancer 247
Cancer, definition 246—247
Cancer, genetic alterations 249—250 334 334
Cancer, malignancy-related alterations 248—249
Carbachol 39
Carbarmylcholine see “Carbachol”
Cardiac muscle, signalling 166 182 185
Cartilage link proteins 324—325
Caspase activated DNAase see “CAD”
Caspase-3 328
Caspase-8 339
Caspase-9 326 339
Caspases, apoptosis 335—338
Caspases, cellular targets 336—337 337
Caspases, effector 335 337
Caspases, initiator 335 337
Caspases, regulation 338
Catecholamines 2 32 33 34 194
Catecholamines, 7TM receptors 38
Catecholamines, receptor binding 55 56
Catenins 322 332
CBP (CREB binding protein) 194—195
CC chemokines 351 351 352
CD28 288
CD3 285 286
CD4 285 286 290
CD44 324—325 324
CD45 (leukocyte common antigen) 286 376—377 377
CD8 285 286 290
Cdc20 238 244 245 246
Cdc25 95 108 238
Cdc42 310
Cdc53 (Cullin) 246
Cdhl 238 240 246
CDK inhibitors 240—242 241
CDK-activating kinase see “CAK”
CDK1 237 238 243
CDK2 236 237 241 330 407
CDK4 235 236 240 241 330
CDK6 235 236 241
CDK7 235 407
CDKs (cyclin-dependent protein kinases) 234
CED genes 335
Cell culture, historical aspects 230—231 231
Cell cycle 232—246
Ðåêëàìà